Logo image of CLFD

CLEARFIELD INC (CLFD) Stock Fundamental Analysis

NASDAQ:CLFD - Nasdaq - US18482P1030 - Common Stock - Currency: USD

38.3  -0.59 (-1.52%)

After market: 38.1 -0.2 (-0.52%)

Fundamental Rating

5

Taking everything into account, CLFD scores 5 out of 10 in our fundamental rating. CLFD was compared to 49 industry peers in the Communications Equipment industry. CLFD has a great financial health rating, but its profitability evaluates not so good. CLFD is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

CLFD had negative earnings in the past year.
In the past year CLFD had a positive cash flow from operations.
CLFD had positive earnings in 4 of the past 5 years.
In the past 5 years CLFD always reported a positive cash flow from operatings.
CLFD Yearly Net Income VS EBIT VS OCF VS FCFCLFD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

1.2 Ratios

CLFD has a Return On Assets of -0.60%. This is comparable to the rest of the industry: CLFD outperforms 57.14% of its industry peers.
The Return On Equity of CLFD (-0.70%) is better than 61.22% of its industry peers.
Industry RankSector Rank
ROA -0.6%
ROE -0.7%
ROIC N/A
ROA(3y)8.92%
ROA(5y)10.11%
ROE(3y)13.09%
ROE(5y)13.53%
ROIC(3y)N/A
ROIC(5y)N/A
CLFD Yearly ROA, ROE, ROICCLFD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

1.3 Margins

The Gross Margin of CLFD (24.54%) is worse than 81.63% of its industry peers.
In the last couple of years the Gross Margin of CLFD has declined.
CLFD does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 24.54%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-26.4%
GM growth 5Y-14.74%
CLFD Yearly Profit, Operating, Gross MarginsCLFD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30 40

More info and screens

9

2. Health

2.1 Basic Checks

CLFD does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CLFD has less shares outstanding
The number of shares outstanding for CLFD has been increased compared to 5 years ago.
The debt/assets ratio for CLFD has been reduced compared to a year ago.
CLFD Yearly Shares OutstandingCLFD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
CLFD Yearly Total Debt VS Total AssetsCLFD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

CLFD has an Altman-Z score of 8.74. This indicates that CLFD is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 8.74, CLFD belongs to the top of the industry, outperforming 91.84% of the companies in the same industry.
CLFD has a debt to FCF ratio of 0.42. This is a very positive value and a sign of high solvency as it would only need 0.42 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.42, CLFD belongs to the top of the industry, outperforming 83.67% of the companies in the same industry.
CLFD has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.02, CLFD is doing good in the industry, outperforming 69.39% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.42
Altman-Z 8.74
ROIC/WACCN/A
WACC10.1%
CLFD Yearly LT Debt VS Equity VS FCFCLFD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

CLFD has a Current Ratio of 6.76. This indicates that CLFD is financially healthy and has no problem in meeting its short term obligations.
CLFD has a Current ratio of 6.76. This is amongst the best in the industry. CLFD outperforms 93.88% of its industry peers.
CLFD has a Quick Ratio of 4.92. This indicates that CLFD is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of CLFD (4.92) is better than 93.88% of its industry peers.
Industry RankSector Rank
Current Ratio 6.76
Quick Ratio 4.92
CLFD Yearly Current Assets VS Current LiabilitesCLFD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 44.00% over the past year.
The Revenue has decreased by -2.14% in the past year.
CLFD shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.42% yearly.
EPS 1Y (TTM)44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%122.5%
Revenue 1Y (TTM)-2.14%
Revenue growth 3Y5.79%
Revenue growth 5Y14.42%
Sales Q2Q%27.79%

3.2 Future

The Earnings Per Share is expected to grow by 64.74% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 13.15% on average over the next years. This is quite good.
EPS Next Y116.8%
EPS Next 2Y64.74%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year11.85%
Revenue Next 2Y13.15%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
CLFD Yearly Revenue VS EstimatesCLFD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M 250M
CLFD Yearly EPS VS EstimatesCLFD Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 1 2 3

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

CLFD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
CLFD is valuated quite expensively with a Price/Forward Earnings ratio of 63.11.
61.22% of the companies in the same industry are cheaper than CLFD, based on the Price/Forward Earnings ratio.
CLFD is valuated expensively when we compare the Price/Forward Earnings ratio to 21.76, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 63.11
CLFD Price Earnings VS Forward Price EarningsCLFD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200

4.2 Price Multiples

The rest of the industry has a similar Price/Free Cash Flow ratio as CLFD.
Industry RankSector Rank
P/FCF 29.55
EV/EBITDA N/A
CLFD Per share dataCLFD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

CLFD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CLFD's earnings are expected to grow with 64.74% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y64.74%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CLFD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CLEARFIELD INC

NASDAQ:CLFD (5/23/2025, 9:23:24 PM)

After market: 38.1 -0.2 (-0.52%)

38.3

-0.59 (-1.52%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryCommunications Equipment
Earnings (Last)05-08 2025-05-08/amc
Earnings (Next)07-30 2025-07-30/amc
Inst Owners62.74%
Inst Owner Change-6.27%
Ins Owners7.46%
Ins Owner Change0.19%
Market Cap529.69M
Analysts82
Price Target46.92 (22.51%)
Short Float %9.9%
Short Ratio9.63
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)102.81%
Min EPS beat(2)58.55%
Max EPS beat(2)147.06%
EPS beat(4)4
Avg EPS beat(4)90.82%
Min EPS beat(4)58.55%
Max EPS beat(4)147.06%
EPS beat(8)8
Avg EPS beat(8)90.93%
EPS beat(12)12
Avg EPS beat(12)67.19%
EPS beat(16)16
Avg EPS beat(16)61.09%
Revenue beat(2)1
Avg Revenue beat(2)8.63%
Min Revenue beat(2)-2.78%
Max Revenue beat(2)20.03%
Revenue beat(4)3
Avg Revenue beat(4)10.03%
Min Revenue beat(4)-2.78%
Max Revenue beat(4)20.03%
Revenue beat(8)6
Avg Revenue beat(8)10%
Revenue beat(12)9
Avg Revenue beat(12)11.36%
Revenue beat(16)13
Avg Revenue beat(16)13.18%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)186.96%
EPS NQ rev (3m)186.96%
EPS NY rev (1m)145.9%
EPS NY rev (3m)145.9%
Revenue NQ rev (1m)-0.63%
Revenue NQ rev (3m)-0.63%
Revenue NY rev (1m)1.97%
Revenue NY rev (3m)1.97%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 63.11
P/S 2.97
P/FCF 29.55
P/OCF 19.04
P/B 1.99
P/tB 2.09
EV/EBITDA N/A
EPS(TTM)-0.14
EYN/A
EPS(NY)0.61
Fwd EY1.58%
FCF(TTM)1.3
FCFY3.38%
OCF(TTM)2.01
OCFY5.25%
SpS12.89
BVpS19.23
TBVpS18.33
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.6%
ROE -0.7%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 24.54%
FCFM 10.06%
ROA(3y)8.92%
ROA(5y)10.11%
ROE(3y)13.09%
ROE(5y)13.53%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-26.4%
GM growth 5Y-14.74%
F-Score6
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.42
Debt/EBITDA N/A
Cap/Depr 131.13%
Cap/Sales 5.56%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.76
Quick Ratio 4.92
Altman-Z 8.74
F-Score6
WACC10.1%
ROIC/WACCN/A
Cap/Depr(3y)178.64%
Cap/Depr(5y)139.97%
Cap/Sales(3y)4.08%
Cap/Sales(5y)3.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%122.5%
EPS Next Y116.8%
EPS Next 2Y64.74%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.14%
Revenue growth 3Y5.79%
Revenue growth 5Y14.42%
Sales Q2Q%27.79%
Revenue Next Year11.85%
Revenue Next 2Y13.15%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y14.44%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year136.57%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y34.67%
FCF growth 3Y12.66%
FCF growth 5Y0.7%
OCF growth 1Y24.1%
OCF growth 3Y26.8%
OCF growth 5Y8.57%